Amgen Inc (AMGN) stock
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3026% above fair value
$443.89−14.04 (-3.07%)
Close on Nov 18, 2026Market cap $239.98BP/E 25.7Yield 2.18%
Amgen market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Amgen's market cap was $253.06B on Nov 11, 2026, against $186.03B a year earlier. Over the last 5 years it ranged from $117.89B to $253.06B, with a median of $152.79B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $253.06B | +43.6% |
| 2025 | Dec 31, 2025 | $176.26B | +25.8% |
| 2024 | Dec 31, 2024 | $140.09B | -9.1% |
| 2023 | Dec 29, 2023 | $154.12B | +10.0% |
| 2022 | Dec 30, 2022 | $140.12B | +10.2% |
| 2021 | Dec 31, 2021 | $127.11B | -5.3% |
| 2020 | Dec 31, 2020 | $134.16B | -7.6% |
| 2019 | Dec 31, 2019 | $145.15B | +14.9% |
| 2018 | Dec 31, 2018 | $126.34B | -0.0% |
| 2017 | Dec 29, 2017 | $126.36B | +16.0% |
| 2016 | Dec 30, 2016 | $108.90B | -11.1% |
| 2015 | Dec 31, 2015 | $122.54B | +1.1% |
| 2014 | Dec 31, 2014 | $121.16B | +40.8% |
| 2013 | Dec 31, 2013 | $86.03B | +29.9% |
| 2012 | Dec 31, 2012 | $66.21B | +10.5% |
| 2011 | Dec 30, 2011 | $59.91B | +14.6% |
| 2010 | Dec 31, 2010 | $52.26B | -9.1% |
| 2009 | Dec 31, 2009 | $57.48B | – |
See a number that looks wrong?